| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | FLJ27505 |
| Uniprot No | 0 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-134aa |
| 氨基酸序列 | MASGKDTCPTLPKLTNNCSDESLYKSANKYEEIHLPRFSLKQGMIPRRYVMPWKENMIFRNVNLKQAEVCGIHTGPLEDSLFLNHSERLCHGEDRKVVFQKGPPEIKIADMPLHSPLSRYQSTVISHGFRRRLV |
| 分子量 | 41.9 kDa |
| 蛋白标签 | GST-tag at N-terminal |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人FLJ27505蛋白的假设性参考文献(注：实际文献可能有限或需要进一步验证)：
1. **文献名称**：*Functional Characterization of Recombinant Human FLJ27505 Protein in Cellular Apoptosis*
**作者**：Chen et al., 2022
**摘要**：研究通过哺乳动物表达系统成功制备重组FLJ27505蛋白，发现其通过激活Caspase-3通路诱导癌细胞凋亡，提示其潜在的肿瘤治疗价值。
2. **文献名称**：*Expression and Purification of FLJ27505 in E. coli: Structural Insights and Interaction Partners*
**作者**：Kimura et al., 2020
**摘要**：利用大肠杆菌系统高效表达并纯化FLJ27505蛋白，结合质谱分析鉴定了其与线粒体膜蛋白的相互作用，推测其参与细胞能量代谢调控。
3. **文献名称**：*FLJ27505 as a Novel Biomarker in Chronic Inflammation: Recombinant Protein-Based Analysis*
**作者**：Gomez et al., 2021
**摘要**：通过ELISA和重组FLJ27505蛋白实验，证实其在炎症患者血清中表达上调，可能通过NF-κB通路促进炎症因子释放。
4. **文献名称**：*The Role of FLJ27505 in Neuronal Development: Insights from Recombinant Protein Overexpression*
**作者**：Li et al., 2019
**摘要**：在神经元细胞中过表达重组FLJ27505蛋白，发现其促进轴突生长并调控突触可塑性，可能与神经发育疾病相关。
**备注**：上述内容为基于学术文献常见主题的模拟示例。若需实际文献，建议通过NCBI PubMed或Google Scholar以“FLJ27505 protein”、“recombinant FLJ27505”为关键词检索，或查询UniProt数据库(ID: [Q8N4Q6](https://www.uniprot.org/uniprotkb/Q8N4Q6/entry))获取更新信息。
Here’s a concise description of recombinant human FLJ27505 protein:
Recombinant human FLJ27505 protein is a genetically engineered version of a poorly characterized protein encoded by the FLJ27505 gene (also known as C1orf123), located on chromosome 1 in humans. This protein belongs to the "uncharacterized protein family" with limited functional annotation in current databases. Structural predictions suggest it may contain conserved domains indicative of enzymatic or regulatory functions, though its exact biological role remains unclear. Recombinant production typically involves heterologous expression systems (e.g., E. coli or mammalian cells) with affinity tags to enable purification and detection.
Interest in this protein stems from emerging links to cellular processes observed in transcriptomic studies, particularly its potential involvement in metabolic regulation or stress responses. Some preliminary studies associate its expression patterns with tumor progression, though validation is ongoing. The recombinant form facilitates biochemical characterization, antibody production, and functional studies to elucidate its molecular interactions and pathways. Current research focuses on resolving its three-dimensional structure, post-translational modifications, and tissue-specific expression profiles to clarify its physiological significance. As an understudied protein, FLJ27505 represents a frontier in proteomic exploration with potential implications for understanding human diseases and developing diagnostic markers.
×
